Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients

被引:3
作者
Czibor, Sandor [1 ]
Carr, Robert [2 ]
Redondo, Francisca [3 ]
Auewarakul, Chirayu U. [4 ]
Cerci, Juliano J. [5 ]
Paez, Diana [6 ]
Fanti, Stefano [7 ]
Gyorke, Tamas [1 ]
机构
[1] Semmelweis Univ, Med Imaging Ctr, Dept Nucl Med, Budapest, Hungary
[2] Kings Coll London, Guys & St Thomas Hosp, Dept Hematol, London, England
[3] Fdn Arturo Lopez Perez, Oncol Clin, Santiago, Chile
[4] Chulabhorn Royal Acad, HRH Princess Chulabhorn Coll Med Sci, Fac Med & Publ Hlth, Bangkok, Thailand
[5] PET CT Dept Quanta Diagnost & Terapia, Curitiba, Brazil
[6] IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
[7] Univ Bologna, Policlin S Orsola, Metropolitan Nucl Med, Bologna, Italy
关键词
diffuse large B-cell lymphoma; Deauville score; PET; metabolic tumor volume; ratio PET; METABOLIC TUMOR VOLUME; PROGRESSION-FREE SURVIVAL; HODGKIN-LYMPHOMA; RESPONSE ASSESSMENT; FDG-PET/CT; PREDICTION; CRITERIA; IPI;
D O I
10.1097/MNM.0000000000001664
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective2-[F-18]fluoro-2-deoxy-d-glucose PET/computed tomography ([F-18]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. MethodsWe investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (Delta SUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. ResultsA total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different.Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, Delta SUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that Delta SUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). ConclusionBaseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative 'Deauville-like' parameters performing best in the present study.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 42 条
[1]   EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies [J].
Aide, Nicolas ;
Lasnon, Charline ;
Veit-Haibach, Patrick ;
Sera, Terez ;
Sattler, Bernhard ;
Boellaard, Ronald .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 :S17-S31
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) [J].
Annunziata, Salvatore ;
Cuccaro, Annarosa ;
Calcagni, Maria Lucia ;
Hohaus, Stefan ;
Giordano, Alessandro ;
Rufini, Vittoria .
ANNALS OF NUCLEAR MEDICINE, 2016, 30 (08) :588-592
[4]   Correlation of 18-fluorodeoxyglucose PET/computed tomography parameters and clinical features to predict outcome for diffuse large B-cell lymphoma [J].
Baratto, Lucia ;
Wu, Fengyu ;
Minamimoto, Ryogo ;
Hatami, Negin ;
Liang, Tie ;
Sabile, Jean ;
Advani, Ranjana H. ;
Mittra, Erik .
NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (07) :792-799
[5]   Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden [J].
Barrington, Sally E. ;
Meignan, Michel .
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (08) :1096-1102
[6]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[7]   Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma [J].
Carr, Robert ;
Fanti, Stefano ;
Paez, Diana ;
Cerci, Juliano ;
Gyoerke, Tamas ;
Redondo, Francisca ;
Morris, Tim P. ;
Meneghetti, Claudio ;
Auewarakul, Chirayu ;
Nair, Reena ;
Gorospe, Charity ;
Chung, June-Key ;
Kuzu, Isinsu ;
Celli, Monica ;
Gujral, Sumeet ;
Padua, Rose Ann ;
Dondi, Maurizio .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (12) :1936-1944
[8]   Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy [J].
Chang, Chin-Chuan ;
Cho, Shih-Feng ;
Chuang, Ya-Wen ;
Lin, Chia-Yang ;
Chang, Shu-Min ;
Hsu, Wen-Ling ;
Huang, Ying-Fong .
ONCOTARGET, 2017, 8 (59) :99587-99600
[9]   Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].
Chapuy, Bjoern ;
Stewart, Chip ;
Dunford, Andrew J. ;
Kim, Jaegil ;
Kamburov, Atanas ;
Redd, Robert A. ;
Lawrence, Mike S. ;
Roemer, Margaretha G. M. ;
Li, Amy J. ;
Ziepert, Marita ;
Staiger, Annette M. ;
Wala, Jeremiah A. ;
Ducar, Matthew D. ;
Leshchiner, Ignaty ;
Rheinbay, Ester ;
Taylor-Weiner, Amaro ;
Coughlin, Caroline A. ;
Hess, Julian M. ;
Pedamallu, Chandra S. ;
Livitz, Dimitri ;
Rosebrock, Daniel ;
Rosenberg, Mara ;
Tracy, Adam A. ;
Horn, Heike ;
van Hummelen, Paul ;
Feldman, Andrew L. ;
Link, Brian K. ;
Novak, Anne J. ;
Cerhan, James R. ;
Habermann, Thomas M. ;
Siebert, Reiner ;
Rosenwald, Andreas ;
Thorner, Aaron R. ;
Meyerson, Matthew L. ;
Golub, Todd R. ;
Beroukhim, Rameen ;
Wulf, Gerald G. ;
Ott, German ;
Rodig, Scott J. ;
Monti, Stefano ;
Neuberg, Donna S. ;
Loeffler, Markus ;
Pfreundschuh, Michael ;
Truemper, Lorenz ;
Getz, Gad ;
Shipp, Margaret A. .
NATURE MEDICINE, 2018, 24 (05) :679-+
[10]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+